IFP Advisors’s Cytosorbents Corp CTSO Stock Holding History

IFP Advisors’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,687	Closed	-$20K	–	3581
2022 Q4	$20K	Buy	1,687 +233	+16%	+$346	﹤0.01%	2871
2022 Q3	$17K	Hold	1,454	–	–	﹤0.01%	3227
2022 Q2	$17K	Hold	1,454	–	–	﹤0.01%	2983
2022 Q1	$17K	Buy	+1,454	New	+$5.21K	﹤0.01%	2983
2021 Q1	–	Sell	-1,967	Closed	-$18.7K	–	3041
2020 Q4	$16K	Hold	1,967	–	–	﹤0.01%	1864
2020 Q3	$16K	Buy	+1,967	New	+$17.7K	﹤0.01%	1728
2018 Q4	–	Sell	-430	Closed	-$6K	–	3582
2018 Q3	$6K	Buy	+430	New	+$5.39K	﹤0.01%	3114
2017 Q4	–	Sell	-5,600	Closed	-$35K	–	3852
2017 Q3	$35K	Hold	5,600	–	–	﹤0.01%	2221
2017 Q2	$24K	Hold	5,600	–	–	﹤0.01%	2462
2017 Q1	$25K	Hold	5,600	–	–	﹤0.01%	2349
2016 Q4	$31K	Hold	5,600	–	–	﹤0.01%	2171
2016 Q3	$36K	Hold	5,600	–	–	﹤0.01%	2010
2016 Q2	$25K	Buy	+5,600	New	+$24.4K	﹤0.01%	2192
2016 Q1	–	Sell	-5,600	Closed	-$31K	–	2569
2015 Q4	$31K	Buy	+5,600	New	+$38.1K	﹤0.01%	1887

Other funds holding CTSO

Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return

Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JAMONY

Jacob Asset Management of New York Hermosa Beach, California $70.9M AUM 14.28% 1-Year Est. Return

IFP Advisors's CTSO Position: Q1 2023 in Review

IFP Advisors sold out of Cytosorbents Corp (CTSO) in Q1 2023, closing a stake of 1,687 shares — an estimated $20K sold.

IFP Advisors first reported a position in CTSO in Q4 2015 and held it in 14 quarters. The position peaked at $36K in Q3 2016. 59 funds tracked by Wall St. Rank hold CTSO as of Q1 2023.

IFP Advisors reported no remaining Cytosorbents Corp position as of Q1 2023 after selling out during the quarter.
IFP Advisors sold 1,687 Cytosorbents Corp shares in Q1 2023, an estimated $20K.
IFP Advisors first reported a position in Cytosorbents Corp in Q4 2015 and held it in 14 quarters.
IFP Advisors's Cytosorbents Corp position peaked at $36K in Q3 2016.
59 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2023.

Based on IFP Advisors's 13F filing for Q1 2023, filed 18 Apr 2023.